Indoco Remedies

{
  "main_header": {
    "sid": 601817,
    "name": "Indoco Remedies",
    "stock_name": "Indoco Remedies",
    "full_name": "Indoco Remedies Ltd",
    "name_url": "stocks-analysis/indoco-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "205.10",
    "chg": -8.65,
    "chgp": "-4.05%",
    "dir": -1,
    "prev_price": "213.75",
    "mcapval": "2,004.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532612,
    "symbol": "INDOCO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE873D01024",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "1.63 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indoco-remedies-601817-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indoco Remedies Ltd’s Volatile Week: 11.01% Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltds-volatile-week-1101-surge-amid-mixed-technical-signals-3826504",
        "imagepath": "",
        "date": "2026-02-07 16:10:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens weak at Rs.211.60, down 2.67%</p>\n                    <p><strong>3 Feb:</strong> Intraday high of Rs.245.45 with 11.01% surge</p>\n                    <p><strong>4 Feb:</strong> Price momentum shifts with 10.11% gain amid mixed technical signals</p>\n                    <p><strong>5 Feb:</strong> Bearish momentum returns, stock declines 0.29%</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.213.75, down 4.89% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.217.40</div></div>\n                    <di..."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-3825802",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndocoRemediesL_mojoScore_3825802.png",
        "date": "2026-02-07 10:10:19",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 December 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 07 February 2026, providing investors with the latest data to understand the stock’s standing today."
      },
      {
        "title": "Why is Indoco Remedies Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indoco-remedies-ltd-fallingrising-3825402",
        "imagepath": "",
        "date": "2026-02-07 00:40:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Indoco Remedies has experienced a steady downward trajectory over recent sessions, with the stock falling for three consecutive days and losing nearly 9.75% in that period. Despite an intraday high of Rs 229.45, the stock ultimately traded closer to its intraday low of Rs 212, indicating selling pressure. The weighted average price suggests that a larger volume of shares exchanged hands near the lower price point, reinforcing bearish momentum. Additionally, the stock exhibited high volatility today, with intraday fluctuations of 5.29%, underscoring uncertainty among traders.</p>\n<p>From a technical standpoint, Indoco Remedies is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day average..."
      },
      {
        "title": "Indoco Remedies Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-faces-bearish-momentum-amid-technical-downturn-3821668",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndocoRemediesL_technicaldot_3821668.png",
        "date": "2026-02-05 08:02:49",
        "description": "Indoco Remedies Ltd has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend. The stock’s recent decline of 3.79% on 5 Feb 2026, coupled with deteriorating moving averages and bearish MACD readings, underscores growing investor caution in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Indoco Remedies Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3819669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndocoRemediesL_technicaldot_3819669.png",
        "date": "2026-02-04 08:03:27",
        "description": "Indoco Remedies Ltd has experienced a notable shift in price momentum, reflected in a 10.11% surge in its share price to ₹233.00 on 4 Feb 2026. Despite this sharp intraday gain, the pharmaceutical company’s technical indicators present a complex picture, with a transition from bearish to mildly bearish trends and a recent downgrade to a Strong Sell rating by MarketsMOJO. This article analyses the evolving technical landscape and what it means for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Are Indoco Remedies Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indoco-remedies-ltd-latest-results-good-or-bad-3818917",
        "imagepath": "",
        "date": "2026-02-03 19:15:21",
        "description": "Indoco Remedies Ltd's latest financial results for Q3 FY26 reveal significant challenges in its operational performance. The company reported a net loss of ₹29.79 crores, which represents a substantial widening of losses both quarter-on-quarter and year-on-year. Specifically, the losses increased by 275.66% compared to the previous quarter, while year-on-year losses rose by 12.88%. This trend underscores ongoing structural challenges within the organization.\n\nRevenue for the quarter declined by 8.11% to ₹445.36 crores, reversing the positive growth trend seen in the previous quarter, where revenues had increased by 10.23%. Despite a modest year-on-year revenue growth of 8.48%, this has not translated into improved profitability, as indicated by the operating margin, which contracted to 7.25% from 9.12% in the prior quarter.\n\nThe company's interest burden has also escalated, with interest expenses reaching ₹..."
      },
      {
        "title": "Indoco Remedies Q3 FY26: Mounting Losses Deepen as Operational Challenges Persist",
        "link": "https://www.marketsmojo.com/news/result-analysis/indoco-remedies-q3-fy26-mounting-losses-deepen-as-operational-challenges-persist-3818718",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndocoRemedies_quaterlyResult_3818718.png",
        "date": "2026-02-03 14:33:05",
        "description": "Indoco Remedies Ltd., a Mumbai-based pharmaceutical company with operations spanning 55 countries, reported a consolidated net loss of ₹29.79 crores for Q3 FY26 (October-December 2025), marking a significant deterioration from the ₹7.93 crores loss posted in the previous quarter. The stock surged 11.53% on February 3, 2026, to close at ₹236.00, though this represents a 32.20% decline from its 52-week high of ₹348.10, reflecting persistent investor concerns about the company's ability to return to profitability."
      },
      {
        "title": "Indoco Remedies Ltd Hits Intraday High with 9.22% Surge on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-hits-intraday-high-with-922-surge-on-3-feb-2026-3817509",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndocoRemediesL_priceRelatedfactors_3817509.png",
        "date": "2026-02-03 09:34:18",
        "description": "Indoco Remedies Ltd demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 245.45, marking a significant 9.22% gain. The pharmaceutical company outpaced its sector and broader market indices amid heightened volatility and positive trading momentum."
      },
      {
        "title": "Indoco Remedies Ltd Opens with Strong Gap Up Reflecting Positive Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-opens-with-strong-gap-up-reflecting-positive-market-momentum-3817503",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndocoRemediesL_gapup_3817503.png",
        "date": "2026-02-03 09:33:36",
        "description": "Indoco Remedies Ltd witnessed a significant gap up at the opening bell on 3 Feb 2026, surging 6.36% higher than its previous close. This strong start was accompanied by notable intraday volatility and an overall outperformance relative to its sector and the broader market, signalling a shift in trading dynamics after two consecutive days of decline."
      }
    ],
    "total": 533,
    "sid": "601817",
    "stock_news_url": "https://www.marketsmojo.com/news/indoco-remedies-601817"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Feb-2026",
      "details": "Publication of Unaudited Standalone & Consolidated Financial Results for the Quarter and Nine Months ended 31-12-2025",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter And Nine Months Ended 31St December 2025",
      "datetime": "03-Feb-2026",
      "details": "Approval of Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "03-Feb-2026",
      "details": "Audio recording of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months Ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has declared <strong>10%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indoco Remedies Ltd’s Volatile Week: 11.01% Surge Amid Mixed Technical Signals

2026-02-07 16:10:23

Key Events This Week

2 Feb: Stock opens weak at Rs.211.60, down 2.67%

3 Feb: Intraday high of Rs.245.45 with 11.01% surge

4 Feb: Price momentum shifts with 10.11% gain amid mixed technical signals

5 Feb: Bearish momentum returns, stock declines 0.29%

6 Feb: Week closes at Rs.213.75, down 4.89% on the day

Week Open

Rs.217.40

Read full news article

Indoco Remedies Ltd is Rated Strong Sell

2026-02-07 10:10:19

Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 December 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 07 February 2026, providing investors with the latest data to understand the stock’s standing today.

Read full news article

Why is Indoco Remedies Ltd falling/rising?

2026-02-07 00:40:45

Recent Price Movement and Market Performance

Indoco Remedies has experienced a steady downward trajectory over recent sessions, with the stock falling for three consecutive days and losing nearly 9.75% in that period. Despite an intraday high of Rs 229.45, the stock ultimately traded closer to its intraday low of Rs 212, indicating selling pressure. The weighted average price suggests that a larger volume of shares exchanged hands near the lower price point, reinforcing bearish momentum. Additionally, the stock exhibited high volatility today, with intraday fluctuations of 5.29%, underscoring uncertainty among traders.

From a technical standpoint, Indoco Remedies is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day average...

Read full news article

Indoco Remedies Ltd Faces Bearish Momentum Amid Technical Downturn

2026-02-05 08:02:49

Indoco Remedies Ltd has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend. The stock’s recent decline of 3.79% on 5 Feb 2026, coupled with deteriorating moving averages and bearish MACD readings, underscores growing investor caution in the Pharmaceuticals & Biotechnology sector.

Read full news article

Indoco Remedies Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-02-04 08:03:27

Indoco Remedies Ltd has experienced a notable shift in price momentum, reflected in a 10.11% surge in its share price to ₹233.00 on 4 Feb 2026. Despite this sharp intraday gain, the pharmaceutical company’s technical indicators present a complex picture, with a transition from bearish to mildly bearish trends and a recent downgrade to a Strong Sell rating by MarketsMOJO. This article analyses the evolving technical landscape and what it means for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Are Indoco Remedies Ltd latest results good or bad?

2026-02-03 19:15:21

Indoco Remedies Ltd's latest financial results for Q3 FY26 reveal significant challenges in its operational performance. The company reported a net loss of ₹29.79 crores, which represents a substantial widening of losses both quarter-on-quarter and year-on-year. Specifically, the losses increased by 275.66% compared to the previous quarter, while year-on-year losses rose by 12.88%. This trend underscores ongoing structural challenges within the organization. Revenue for the quarter declined by 8.11% to ₹445.36 crores, reversing the positive growth trend seen in the previous quarter, where revenues had increased by 10.23%. Despite a modest year-on-year revenue growth of 8.48%, this has not translated into improved profitability, as indicated by the operating margin, which contracted to 7.25% from 9.12% in the prior quarter. The company's interest burden has also escalated, with interest expenses reaching ₹...

Read full news article

Indoco Remedies Q3 FY26: Mounting Losses Deepen as Operational Challenges Persist

2026-02-03 14:33:05

Indoco Remedies Ltd., a Mumbai-based pharmaceutical company with operations spanning 55 countries, reported a consolidated net loss of ₹29.79 crores for Q3 FY26 (October-December 2025), marking a significant deterioration from the ₹7.93 crores loss posted in the previous quarter. The stock surged 11.53% on February 3, 2026, to close at ₹236.00, though this represents a 32.20% decline from its 52-week high of ₹348.10, reflecting persistent investor concerns about the company's ability to return to profitability.

Read full news article

Indoco Remedies Ltd Hits Intraday High with 9.22% Surge on 3 Feb 2026

2026-02-03 09:34:18

Indoco Remedies Ltd demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 245.45, marking a significant 9.22% gain. The pharmaceutical company outpaced its sector and broader market indices amid heightened volatility and positive trading momentum.

Read full news article

Indoco Remedies Ltd Opens with Strong Gap Up Reflecting Positive Market Momentum

2026-02-03 09:33:36

Indoco Remedies Ltd witnessed a significant gap up at the opening bell on 3 Feb 2026, surging 6.36% higher than its previous close. This strong start was accompanied by notable intraday volatility and an overall outperformance relative to its sector and the broader market, signalling a shift in trading dynamics after two consecutive days of decline.

Read full news article

View All News